Douglas G. Tilley

4.5k total citations · 1 hit paper
86 papers, 3.4k citations indexed

About

Douglas G. Tilley is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Douglas G. Tilley has authored 86 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 51 papers in Cardiology and Cardiovascular Medicine and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Douglas G. Tilley's work include Receptor Mechanisms and Signaling (43 papers), Cardiac Fibrosis and Remodeling (18 papers) and Neuropeptides and Animal Physiology (17 papers). Douglas G. Tilley is often cited by papers focused on Receptor Mechanisms and Signaling (43 papers), Cardiac Fibrosis and Remodeling (18 papers) and Neuropeptides and Animal Physiology (17 papers). Douglas G. Tilley collaborates with scholars based in United States, Canada and China. Douglas G. Tilley's co-authors include Howard A. Rockman, Walter J. Koch, Donald H. Maurice, Jonathan D. Violin, Laurel A. Grisanti, Erhe Gao, Il‐man Kim, Daniel Palmer, Sandra L. Jimmo and Rhonda L. Carter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Douglas G. Tilley

85 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection

2007 360 citations Takahisa Noma, Anthony Lemaire et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Douglas G. Tilley

Since Specialization

Citations

This map shows the geographic impact of Douglas G. Tilley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas G. Tilley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas G. Tilley more than expected).

Fields of papers citing papers by Douglas G. Tilley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas G. Tilley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas G. Tilley. The network helps show where Douglas G. Tilley may publish in the future.

Co-authorship network of co-authors of Douglas G. Tilley

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas G. Tilley. A scholar is included among the top collaborators of Douglas G. Tilley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas G. Tilley. Douglas G. Tilley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of cardiomyocyte-specific adhesion G-protein-coupled receptor G1 (ADGRG1/GPR56) promotes pressure overload-induced heart failure 2024 ·Bioscience Reports ·(unknown), (unknown), Rajika Roy, (unknown), (unknown), (unknown), Rhonda L. Carter, Xianhua Piao, Douglas G. Tilley	0
2	Effects of maternal hypothyroidism on postnatal cardiomyocyte proliferation and cardiac disease responses of the progeny 2023 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), Jaslyn Johnson, Yijun Yang, Daohai Yu, Hajime Kubo, Remus M. Berretta, Tao Wang, Xiaoying Zhang, (unknown), Jun Yu, Douglas G. Tilley, Steven R. Houser, Xiongwen Chen	3
3	The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor 2022 ·Cannabis and Cannabinoid Research ·(unknown), (unknown), Dow P. Hurst, (unknown), Pingwei Zhao, Douglas G. Tilley, Elke Miess, Stefan Schulz, Mary E. Abood, Patricia H. Reggio	6
4	G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure 2021 ·Cardiovascular Research ·Claudio de Lucia, Laurel A. Grisanti, Giulia Borghetti, (unknown), Jessica Ibetti, Anna Maria Lucchese, Eric W. Barr, Rajika Roy, (unknown), (unknown), Erhe Gao, Giuseppe Rengo, Steven R. Houser, Douglas G. Tilley, Walter J. Koch	32
5	Epidermal growth factor receptor-dependent maintenance of cardiac contractility 2021 ·Cardiovascular Research ·Shuchi Guo, (unknown), (unknown), (unknown), Rhonda L. Carter, (unknown), Toby P. Thomas, (unknown), Jianliang Song, (unknown), Thomas G. Martin, Erhe Gao, Sudarsan Rajan, Jonathan A. Kirk, Walter J. Koch, Joseph Y. Cheung, Douglas G. Tilley	14
6	Prior beta blocker treatment decreases leukocyte responsiveness to injury 2019 ·JCI Insight ·Laurel A. Grisanti, Claudio de Lucia, Toby P. Thomas, (unknown), John Strony, Valerie D. Myers, (unknown), Daohai Yu, Celestino Sardu, Raffaele Marfella, Erhe Gao, Steven R. Houser, Walter J. Koch, (unknown), Douglas G. Tilley	25
7	Muscarinic receptors promote pacemaker fate at the expense of secondary conduction system tissue in zebrafish 2019 ·JCI Insight ·(unknown), Martin D. Burkhalter, (unknown), Laurel A. Grisanti, (unknown), (unknown), Cornelia Donow, Monika Kustermann, (unknown), Yinghong Cui, Farah Raad, (unknown), Alessandra Moretti, Wolfram‐H. Zimmermann, Jürgen Wess, Michael Kühl, Carsten Hoffmann, Douglas G. Tilley, Melanie Philipp	13
8	G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart 2018 ·Journal of Molecular and Cellular Cardiology ·Jessica Pfleger, Polina Gross, Jaslyn Johnson, Rhonda L. Carter, Erhe Gao, Douglas G. Tilley, Steven R. Houser, Walter J. Koch	21
9	Restricting mitochondrial GRK2 post-ischemia confers cardioprotection by reducing myocyte death and maintaining glucose oxidation 2018 ·Science Signaling ·Priscila Y. Sato, J. Kurt Chuprun, Laurel A. Grisanti, (unknown), (unknown), Rajika Roy, Christopher J. Traynham, Jessica Ibetti, Anna Maria Lucchese, Ancai Yuan, Konstantinos Drosatos, Douglas G. Tilley, Erhe Gao, Walter J. Koch	38
10	Arginine vasopressin receptor signaling and functional outcomes in heart failure 2015 ·Cellular Signalling ·(unknown), Valerie D. Myers, Fabio A. Recchia, Arthur M. Feldman, Douglas G. Tilley	35
11	The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray 2015 ·Molecular Pharmacology ·Elena Deliu, (unknown), Linda Console‐Bram, Rhonda L. Carter, Douglas G. Tilley, (unknown), Lynn G. Kirby, G. Cristina Brailoiu, Eugen Brailoiu, Khalid Benamar, Mary E. Abood	48
12	β-Adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1/2 and Akt 2014 ·Journal of Molecular and Cellular Cardiology ·Laurel A. Grisanti, (unknown), Rhonda L. Carter, Justine Yu, (unknown), Scott Radcliffe, (unknown), Catherine A. Makarewich, Steven R. Houser, Douglas G. Tilley	38
13	Convergence of G Protein–Coupled Receptor and S-Nitrosylation Signaling Determines the Outcome to Cardiac Ischemic Injury 2013 ·Science Signaling ·Z. Maggie Huang, Erhe Gao, Fábio V. Fonseca, Hiroki Hayashi, Xiying Shang, Nicholas E. Hoffman, J. Kurt Chuprun, Xufan Tian, Douglas G. Tilley, Muniswamy Madesh, David J. Lefer, Jonathan S. Stamler, Walter J. Koch	90
14	Vasopressin Antagonists for Patients With Acute Heart Failure: Interpreting New Clinical and Translational Data 2013 ·Clinical Pharmacology & Therapeutics ·Arthur M. Feldman, Abdullah Hamad, Emily J. Tsai, Wuqiang Zhu, Douglas G. Tilley, (unknown), Joseph Y. Cheung	4
15	Cardiac Progenitor Cells Engineered With βARKct Have Enhanced β-Adrenergic Tolerance 2013 ·Molecular Therapy ·Mohsin Khan, Sadia Mohsin, Haruhiro Toko, (unknown), Jonathan Nguyen, Silvia Truffa, Natalie Gude, (unknown), Douglas G. Tilley, Walter J. Koch, Mark A. Sussman	11
16	Troglitazone stimulates β-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor 2010 ·Biochemical and Biophysical Research Communications ·Douglas G. Tilley, (unknown), Howard A. Rockman	14
17	β-Arrestin Mediates β1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream Signaling 2009 ·Journal of Biological Chemistry ·Douglas G. Tilley, Il‐man Kim, Priyesh Patel, Jonathan D. Violin, Howard A. Rockman	85
18	β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection breakdown → 2007 ·Journal of Clinical Investigation ·Takahisa Noma, Anthony Lemaire, Sathyamangla V. Naga Prasad, Liza Barki‐Harrington, Douglas G. Tilley, (unknown), Philippe Le Corvoisier, Jonathan D. Violin, Huijun Wei, Robert J. Lefkowitz, Howard A. Rockman	360
19	Vascular Smooth Muscle Cell Phenotype-Dependent Phosphodiesterase 4D Short Form Expression: Role of Differential Histone Acetylation on cAMP-Regulated Function 2005 ·Molecular Pharmacology ·Douglas G. Tilley, Donald H. Maurice	37
20	Vascular Smooth Muscle Cell Phosphodiesterase (PDE) 3 and PDE4 Activities and Levels are Regulated by Cyclic AMP in Vivo 2002 ·Molecular Pharmacology ·Douglas G. Tilley, Donald H. Maurice	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact